Combining immunotherapy with radiotherapy for glioblastoma: recent advances and challenges
Glioblastoma (GBM) is an extremely aggressive brain tumor. Its standard treatment currently involves surgery followed by radiotherapy and temozolomide. However, recurrence is frequently unavoidable, and the effect of various treatments is not ideal due to numerous inherent obstacles. Immunotherapy h...
| Published in: | Frontiers in Oncology |
|---|---|
| Main Authors: | , , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-05-01
|
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2025.1523675/full |
